Correlation of baseline mRNA levels for NR5A2 and NANOG with treatment outcomes revealed a highly significant separation between responders and non-responders (Fig. 5 D), suggesting that these biomarkers may serve as predictive indicators of therapeutic efficacy.
← all excerpts
Epigenetic regulation of NR5A2 influences colorectal cancer cell stemness via a stemness-related transcription factor NANOG.
1
—
—